J.E. Tateson

1.3k total citations · 1 hit paper
17 papers, 1.1k citations indexed

About

J.E. Tateson is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, J.E. Tateson has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 6 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in J.E. Tateson's work include Inflammatory mediators and NSAID effects (5 papers), Synthesis and Reactions of Organic Compounds (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). J.E. Tateson is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Synthesis and Reactions of Organic Compounds (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). J.E. Tateson collaborates with scholars based in United Kingdom. J.E. Tateson's co-authors include Salvador Moncada, John R. Vane, Roger Randall, L.G. Garland, John A. Salmon, Graham D. Spacey, Robert W. Bonser, H. F. Hodson, Charles H. Reynolds and P. Bhattacherjee and has published in prestigious journals such as The Lancet, Biochemical Journal and FEBS Letters.

In The Last Decade

J.E. Tateson

17 papers receiving 998 citations

Hit Papers

Effects of prostacyclin (PGX) on cyclic AMP concentration... 1977 2026 1993 2009 1977 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.E. Tateson United Kingdom 11 379 339 263 193 171 17 1.1k
N.H. Wilson United Kingdom 17 595 1.6× 422 1.2× 311 1.2× 175 0.9× 111 0.6× 34 1.2k
Randy T. McConnell United States 18 476 1.3× 805 2.4× 274 1.0× 185 1.0× 201 1.2× 23 1.7k
C. G. Van Arman United States 16 386 1.0× 317 0.9× 132 0.5× 140 0.7× 74 0.4× 30 1.2k
Michael A. Trevethick United Kingdom 19 377 1.0× 376 1.1× 359 1.4× 76 0.4× 104 0.6× 36 1.2k
Giovanna Santini Italy 12 419 1.1× 265 0.8× 91 0.3× 139 0.7× 59 0.3× 18 884
Angela Wyche United States 17 753 2.0× 393 1.2× 215 0.8× 178 0.9× 146 0.9× 22 1.5k
Giuliana Leoncini Italy 23 263 0.7× 406 1.2× 311 1.2× 134 0.7× 75 0.4× 91 1.4k
Johan Beetens Belgium 17 182 0.5× 221 0.7× 159 0.6× 163 0.8× 78 0.5× 39 829
Sandra Austin United States 12 675 1.8× 365 1.1× 144 0.5× 431 2.2× 86 0.5× 15 1.4k
Susan Rittenhouse-Simmons United States 8 303 0.8× 648 1.9× 172 0.7× 142 0.7× 82 0.5× 10 1.3k

Countries citing papers authored by J.E. Tateson

Since Specialization
Citations

This map shows the geographic impact of J.E. Tateson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.E. Tateson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.E. Tateson more than expected).

Fields of papers citing papers by J.E. Tateson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.E. Tateson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.E. Tateson. The network helps show where J.E. Tateson may publish in the future.

Co-authorship network of co-authors of J.E. Tateson

This figure shows the co-authorship network connecting the top 25 collaborators of J.E. Tateson. A scholar is included among the top collaborators of J.E. Tateson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.E. Tateson. J.E. Tateson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Randall, Roger, K.E. Eakins, G.A. Higgs, John A. Salmon, & J.E. Tateson. (1994). Inhibition of arachidonic acid cyclo-oxygenase and lipoxygenase activities of leukocytes by indomethacin and compound BW755C. Inflammation Research. 43(3-4). 176–178. 3 indexed citations
2.
3.
Khan, Masood, J.E. Tateson, A. Victor Hoffbrand, & R. Gitendra Wickremasinghe. (1993). Evidence that endogenous generation of leukotrienes does not regulate proliferation of malignant hemopoietic cell lines. Leukemia Research. 17(3). 241–245. 16 indexed citations
4.
Bonser, Robert W., N. Thompson, Roger Randall, et al.. (1991). Demethoxyviridin and wortmannin block phospholipase C and D activation in the human neutrophil. British Journal of Pharmacology. 103(1). 1237–1241. 106 indexed citations
5.
Thompson, Neil T., Robert W. Bonser, J.E. Tateson, et al.. (1991). A quantitative investigation into the dependence of Ca2+ mobilisation on changes in inositol 1,4,5‐trisphosphate levels in the stimulated neutrophil. British Journal of Pharmacology. 103(2). 1592–1596. 19 indexed citations
6.
Thompson, N., J.E. Tateson, Roger Randall, et al.. (1990). The temporal relationship between phospholipase activation, diradylglycerol formation and superoxide production in the human neutrophil. Biochemical Journal. 271(1). 209–213. 41 indexed citations
7.
Bhattacherjee, P., N. K. Boughton-Smith, R.L. Follenfant, et al.. (1988). The Effects of a Novel Series of Selective Inhibitors of Arachidonate 5‐Lipoxygenase on Anaphylactic and Inflammatory Responses. Annals of the New York Academy of Sciences. 524(1). 307–320. 27 indexed citations
8.
Tateson, J.E., Roger Randall, Charles H. Reynolds, et al.. (1988). Selective inhibition of arachidonate 5‐lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo. British Journal of Pharmacology. 94(2). 528–539. 150 indexed citations
9.
Randall, Roger, J.E. Tateson, John A. Dawson, & L.G. Garland. (1987). A commentary on the inhibition by retinoids of leukotriene B4 production in leukocytes. FEBS Letters. 214(1). 167–170. 9 indexed citations
10.
Randall, Roger, J.E. Tateson, & L.G. Garland. (1986). Activation and inhibition of 5-lipoxygenase in human polymorphs: comparison with protein kinase C. Biochemical Society Transactions. 14(6). 1153–1154. 2 indexed citations
11.
Copp, F. C., et al.. (1984). 3-N-substituted-amino-1-[3-(trifluoromethyl)phenyl]-2-pyrazolines have enhanced activity against arachidonate 5-lipoxygenase and cyclooxygenase. Biochemical Pharmacology. 33(2). 339–340. 32 indexed citations
12.
Randall, Roger, K.E. Eakins, G.A. Higgs, John A. Salmon, & J.E. Tateson. (1980). Inhibition of arachidonic acid cyclo-oxygenase and lipoxygenase activities of leukocytes by indomethacin and compound BW755C. Inflammation Research. 10(6). 553–555. 93 indexed citations
13.
Goff, Debra A., et al.. (1979). The involvement of dopamine in the central actions of bupropion, a new antidepressant [proceedings].. PubMed. 66(1). 104P–105P. 7 indexed citations
14.
Tateson, J.E., Salvador Moncada, & John R. Vane. (1977). Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets. Prostaglandins. 13(3). 389–397. 515 indexed citations breakdown →
15.
Tateson, J.E. & David G. Trist. (1976). Inhibition of adenosine-3′, 5′-cyclic monophosphate phosphodiesterase by potential antiallergic compounds. Life Sciences. 18(2). 153–161. 15 indexed citations
16.
Garland, L.G., et al.. (1975). DOXANTRAZOLE, AN ANTIALLERGIC AGENT ORALLY EFFECTIVE IN MAN. The Lancet. 305(7917). 1169–1170. 38 indexed citations
17.
Tateson, J.E.. (1970). Early steps in the biosynthesis of mycobactins P and S. Biochemical Journal. 118(5). 747–753. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026